SEC61G identified as a prognostic biomarker of head and neck squamous cell carcinoma. Shi Y, Liang Y, Wang W, Zhang G, et al. Eur Arch Otorhinolaryngol 2021 Jun 25. pii: 10.1007/s00405-021-06955.

Read + Share

Amedeo Smart

Independent Medical Education

Shi Y, Liang Y, Wang W, Zhang G, et al. SEC61G identified as a prognostic biomarker of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2021 Jun 25. pii: 10.1007/s00405-021-06955.
PMID: 34173014